The emergence of pathogenic fungi has become a major global public health concern, with fungal infections posing a significant hazard to human health as resistant strains proliferate. Fungal infections are a silent crisis, as decades of antifungal medication prophylaxis and long-term therapeutic use have facilitated the formation of drug-resistant fungi [1]. A study has shown that 150 million people have serious fungal diseases, close to a billion people are believed to have skin, nail, and hair infections, and tens of millions are associated with mucosal candidiasis [2]. One of the opportunistic fungi that is frequently observed, Candida usually causes superficial mucosal infections but has the ability to penetrate tissue, causing infections that are potentially fatal [3]. Candida species are recognised as one of the major agents associated with nosocomial infections in all tertiary care hospitals. In immunocompromised individuals, infections with Candida lead to invasive mycosis like candidemia. Candidemia is a frequent bloodstream infection worldwide and has a high mortality rate [4]. Pichia kudriavzevii, the environmental teleomorph of Candida krusie, is distantly related to other pathogen-infected Candida species. Candida krusie is responsible for 2% of yeast infections in humans and is an anamorphic (asexual reproduction) strain found in 30% of the Amerindian population, acquired from food or the environment [5]. Teleomorph, the sexual reproductive stage of a fungus, occurs, leading to the formation of sexual spores. The sexual reproductive stage of Candida krusie is represented by Pichia kudriavzevii. Pichia kudriavzevii is among the most relevant etiological agents of candidiasis. Candidiasis is a fungal infection that can manifest in various forms, including superficial infections like oral thrush and vaginal infections [6]. It is most often found in patients with haematological malignancies or receiving long-term azole treatment [7, 8]. Pichia kudriavzevii is particularly important because it is less susceptible to common antifungal agents like fluconazole. This reduced susceptibility complicates treatment, especially in immunocompromised patients [9]. It is concerning for healthcare for specific Candida species for appropriate antifungal treatment. It is concerning that the prevalence of Pichia kudriavzevii-associated infections has been reported to be growing in numerous case study reports [10, 11]. Pichia kudriavzevii belongs to the family Pichiaceae and, in the order Saccharomycetales, is a diploid ascomycete yeast. It produces ovoid or elongated ellipsoidal cells, shows dimorphic growth by pseudohyphae growth, and forms floating biofilm [12, 13].
In recent times, nanotechnology has emerged as a promising strategy for the development of new antimicrobial agents. Researchers from all over the world have accepted metal nanoparticles as a medicinal tool that may be employed in the diagnosis and treatment of a variety of ailments. because of the extensive applications of these particles [14]. Among the various nanomaterials are silver, gold, and platinum. Silver nanoparticles are used as novel antimicrobials, gold nanoparticles are used as drug carriers, and platinum nanoparticles are used in dentistry and bone allografts; all three of them are used in various diagnoses and treatments [15]. Sulfur nanoparticles have gained significant attention due to their low cost, eco-friendliness, non-toxicity, and unique physicochemical properties. The aforesaid features have taken sulfur nanoparticles into consideration by different workers in the field of antimicrobial research [14, 16]. Sulfur is a non-metallic element that is found abundantly in nature and has been used for various medicinal purposes, such as in the field of dermatology, maintaining the health of skin, hair, nails, teeth, muscle, bone, and various metabolic processes of the body [17]. Since ancient times, sulfur has been known to have scabicidal, insecticidal, and fungicidal properties [18]. Sulfur has gained a reputation since it is among the most useful medicines known to humans [14]. Sulfur is used alone or in combination with compounds like salicylic acid and sulfa drugs and has demonstrated efficacy for the treatment of various dermatological conditions [19]. In this context, an attempt has been made to check the efficacy of chemically synthesised sulfur nanoparticles on superficial mycosis caused by Pichia kudriavzevii.